Variations in inflammatory markers in acute myocardial infarction: A longitudinal study;Variações de marcadores inflamatórios no enfarte agudo do miocárdio: Um estudo longitudinal

Revista Portuguesa de Cardiologia

Volumn 26, Issue 12, 2007, Pages 1357-1363

  Napoleão, Patrícia ^a,c   Santos, M Cristina ^a   Selas, Mafalda ^b   Viegas Crespo, Ana M ^a   Pinheiro, Teresa ^a   Ferreira, R Cruz ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

Author keywords

Acute coronary syndromes; CD40 ligand; Inflammation; P selectin; Patient follow up; TNF

Indexed keywords

CD40 LIGAND; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 39349117144     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory Biomarkers in Acute Coronary Syndromes Part 1: Introduction and Cytokines. Circulation 2006;113;72-75.
2. Lowenstein C, Matsushita K. The acute phase response and atherosclerosis. Drug Discov Today Dis Mech 2004;I:17-22.
3. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory Biomarkers in Acute Coronary Syndromes Part IV: Matrix Metalloproteinases and Biomarkers of Platelet Activation. Circulation 2006;113;382-385.
4. Fichtlscherer S, Heeschen C, Zeiher AM. Inflammatory markers and coronary artery disease. Curr Opin Pharmacol 2004;4:12-131.
5. Mason PJ, Chakrabarti S, Albers AA, Rex S, Vitseva O, Varghese S, Freedman JE. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Am J Cardiol 2005, 96:1365.
6. Ohashi Y, Kawashima S, Mori T, Terashima M, Ichikawa S, Ejiri J, Awano K. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction. Int J Cardiol 2006, 112:52-58.
7. Varo N, Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Raunwald E, Schönbeck. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003, 108:1049-1052.
8. Brueckmann M, Bertsch T, Lang S, Sueselbeck T, Wolpert C, Kaden JJ, Jaramillo C, Huhle G, Borggrefe M, Haase KK. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin Chem Lab Med 2004, 42:1132-1139.
9. Lip GYH, Patel JV, Hughes E, Hart RG. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation. Stroke 2007, 38:1229-1237.
10. Shimomura H, Ogawa H, Arai H, Moriyama Y, Takazoe K, Hirai N, Kaikita K, Hirashima O, Misumi K, Soejima H, Nishiyama K, Yasue H. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol 1998, 81:397-400.
11. K. Kaur, A. K. Sharma, Singal PK. Significance of changes in TNFa and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 291:H106-H113.
12. Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, Varma J, Xuan YT, Wu WJ, Tan W, Zhu X, Bolli R. Tumor necrosis factor-· does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 2004, 37:51-61.
13. Li YH, Teng JK, Tsai WC, Tsai LM, Lin LJ, Chen JH. Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction. Am J Cardiol 1997, 80:1218-1221.
14. Shyu KG, Chang H, Lin CC, Kuan P. Circulating intracellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 1996, 109:1627-1630.
15. Mulvihill N, Foley JB, Ghaisas N, Murphy R, Crean P, Walsh M. Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarction. Am J Cardiol 1999, 83_1265-1267.
16. Bereczki D, Nagy E, Pal A, Magyar MT, Balla J. Should soluble CD40 ligand be measured from serum or plasma samples? Arterioscler Thromb Vasc Biol 2003, 23:1129-1130.
17. Varo N, Nuzzo R, Natal C, Libby P, Schönbeck U. Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clin Sci 2006, 111:341-347.
18. Ahn ER, Lander G, Jy W, Bidot CJ, Jimenez JJ, Horstman LL, Ahn YS. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 2004, 114:143-148.